AssetMark’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
AssetMark's ABVX Position: Q3 2026 in Review
AssetMark increased its Abivax (ABVX) stake by 57% in Q3 2026, buying an estimated $51.2K and bringing the position to 1,167 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #1608.
AssetMark first reported a position in ABVX in Q4 2025 and has held it in 4 quarters since. 221 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.
- AssetMark held 1,167 shares of Abivax worth $116K as of Q3 2026.
- AssetMark bought 425 Abivax shares in Q3 2026, an estimated $51.2K.
- Abivax made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #1608 holding.
- AssetMark first reported a position in Abivax in Q4 2025 and has held it in 4 quarters since.
- 221 funds tracked by Wall St. Rank held Abivax as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.